Late Breaker abstract submissions

LATE BREAKER ABSTRACT DEADLINE – NO FURTHER EXTENSIONS WILL BE PROVIDED

11:59 (ACST) Monday 11 July 2022

Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.

SUBMIT ABSTRACT

If you missed the chance to submit an abstract in the first round due to incomplete data, or you have exciting new research, this is your last chance to be included in a fantastic program filled with internationally distinguished speakers, innovative research and clinical practice.

The Late Breaking sessions are informative fast-paced 5-minute presentations. The sessions are dedicated to new information or important findings not fully available before the general abstract deadline. Presentations are five minutes and should have no more than five slides. This session is one of the most popular sessions at the conference and will be live streamed for Virtual attendees.

Late Breaking presentations are held in a single stream, this is an opportunity to present to all conference delegates, and is a popular session with delegates at the conference.

In order to standardise the abstract layout, we kindly ask you to read the abstract submission guidelines carefully and use the appropriate abstract template provided.

Notification regarding late breaking abstract’s status (accepted or rejected) will be sent to the presenting author of the abstract by Friday 19 August 2022.

Abstracts will be accepted for oral and poster Late Breaking presentations.

APSAD has a prize for best Late Breaking Presentation delivered at the Conference. The presenter judged as preparing and delivering the Best Late Breaking Presentation receives a certificate and a book voucher valued at $150. The award will be announced at the closing session of the conference.

There will also be certificates for the runner up and an honourable.

The Late Breaking Presentations are judged on the basis of original scientific importance or clinical or policy relevance, and clarity of presentation.

ABSTRACT

GUIDELINES

Before submitting your abstract, please ensure you read the abstract guidelines and use the appropriate template below:

ABSTRACT

RESOURCES

APSAD has provided the following terminology resources to assist you with your abstract submission and delivery of your presentation. We recommend familiarising yourself with both documents prior to submitting your abstract. The resources available are:

Find out more about the different types of abstracts templates, the abstract mentoring program and conference scholarships. Presented by co-convenor Dr Cassandra Wright.

Presentation Type

The Scientific Advisory Committee welcomes the submission of Late Breaking Abstracts for presentation at the APSAD 2022 Darwin Hybrid Conference for the following presentation types

Oral Presentations

Time Allocated: 5 minutes | 5 slides

Description: Oral presentations on original research findings, case studies, completed projects and theoretical analyses. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.

Practice Based/Service Delivery Oral Presentations

Time Allocated: 5 minutes | 5 slides

Description: Oral presentations analysing issues and solutions to problems in clinical practice, community engagement, education, health promotion and policy. Presentations should be well structured, rigorous and demonstrate a novel contribution to knowledge.

Poster Presentations

Time Allocated: Permanently displayed during the conference. Authors must be standing with their posters during the dedicated Poster Session | Posters will also be available as a PDF on the virtual platform.

Description: Posters can present research, case studies, divisional projects, or clinical topics

Guidelines

The session is dedicated to late-breaking and unpublished findings and cannot be a revision of an abstract submitted during the general abstract submission process. Late Breaking abstracts, containing new information or important findings not (fully) available before the general abstract deadline, can be submitted. For information regarding types of presentations and abstract preparation guidelines please see the abstract guidelines.

Please note that the Late Breaking Abstract deadline is not an extension of the general abstract submission deadline.

Abstracts must be submitted by 11.59am (ACST) Monday 11 July 2022, there will be no extension to the submission closing date.

Before submitting your abstract, please ensure you read the abstract guidelines carefully. Any abstracts that do not conform to the guidelines will not be considered.

Terminology

We expect all presenters to be aware of the potential of language to be stigmatising, here are two recommended guides put together by NUAA and NADA and Girra Maa Indigenous Health to start you thinking on this issue.

The Scientific Advisory Committee may reject any abstract that it feels includes inappropriate or stigmatising language and/or content.

Abstracts Template

The Oral template is divided into two sections that you may use subject to the nature of your work. Please select the relevant section (A or B) from the two options within the template, details below.

We recommend using Section A within the template for work which describes quantitative data or results. Authors should note that the format requires the presence of concrete results, and this will be noted when abstracts are reviewed. In the case of research in progress, where results are pending at the time of submission, we would encourage this to be noted in your submission. Subheadings for Section A are; Introduction and Aims, Design and Methods, Results, Discussion and Conclusions.

We recommend Section B for work which describes qualitative research, mixed methods research, policy analysis, methods papers and/or some empirical studies. Subheadings for Section B are; Introduction/Issues, Method/Approach, Key Findings, Discussions and Conclusions.

Presenters using either section of the Template are encouraged to include the two ‘optional’ points in the template; Implications for Practice or Policy and Implications for Translational Research. If you choose to do so you will be granted an additional *50 words to answer them.

Note: Your abstract will not be considered if it does not conform to the guidelines

The Scientific Advisory Committee may reallocate a presentation type on the basis of time, content, space available and applicability to the Conference themes.

Note: Abstract presenters will be required to fund their own attendance at the conference and should not submit an abstract if this is not possible.

Disclosure of Interest/Ethical Statement

APSAD recognises the considerable contribution that industry partners make to professional and research activities. We also recognise the need for transparency of disclosure of potential conflicts of interest by acknowledging these relationships in publications and presentations.

For an example of a disclosure of interest/ethical statement please see below:

Dr Smith has received funding from Metabolism Corp. No pharmaceutical grants were received in the development of this study.

Note: If accepted into the program you will be requested to include a disclosure of interest slide into your presentation or include such statements in your poster.

Selection Criteria

Abstracts will be favoured at review if they incorporate:

Completed rather than future work (i.e., final results)
Original data of high quality.
An analysis that extends existing knowledge
Clarity of methodology, analysis and presentation of results
Specific rather than general findings

In balancing the program, the committee may require authors to present their work in an alternate format (e.g., as a poster rather than oral presentation).

Note: We encourage abstracts that are based on Indigenous issues be presented by Indigenous persons, or an Indigenous co-presenter be included. If this is not possible, please include some information as to whether any member of the Indigenous community in which the research is based was involved in development of the research protocol or in conducting the research. Where possible this applies to other population groups as well.

Themes for Submission

Authors must select one primary and one secondary theme of the following that their abstract relates to.

Addiction Reconceptualised

Adolescents / Youth

Aetiology (Incl. Genetics)

Alcohol

Blood-Borne Viruses (Incl. STI)

Cannabis

Children & Families

Coercive Treatment

Cognitive Impairment Training

Comorbidity

Consumers & Peers

COVID-19

Crime, Justice, & Legal Issues

Cross Culture & International

Drug Monitoring / Novel Psychoactive

Drug Policy Reform

Ecstasy & Emerging Psychoactive Substances

E-Health – Behavioural Change

Epidemiology

First Peoples

Gambling

Harms & Harm Reduction

Health Policy & Reforms

Health, Law & Human Rights

Health Services & Systems

Heroin & Opioids

Injecting Drug Use

Innovative Prescribing: Medicinal Cannabis, E-Cigs, etc.

LGBTIQ

Methamphetamine & Psychostimulants

Neuroscience

New Technologies & E-Interventions

Older Adults

Other AOD Issues

Overdose

Over The Counter Codeine Rescheduling

Pharmaceuticals (Consumption)

Prescription Opioid Treatment

Prevention & Early Intervention

Primary Care – Pharmacy in Primary Care

Prisons & Prisoner Health

Psychopharmacology & Psychobiology

Regional Challenges & Innovations

Social & Community Issues

Special Populations

Tobacco & Tobacco Cessation

Translational Research

Treatment Settings

Treatment & Interventions

Well At Work

Women & Maternal Issues

Workforce Issues

Notification of Acceptance

Notifications of acceptance will be sent via e-mail to the submitting author by Friday 19 August 2022. Abstracts submitted for oral will also be considered and reviewed for a poster presentation.

Publication in the Drug and Alcohol Review

Accepted abstracts will be published in a supplement of the Drug and Alcohol Review distributed at the conference.

The Drug and Alcohol Review is APSAD’s official journal and is Asia-Pacific’s leading multidisciplinary journal addressing issues related to alcohol and drug-related problems. Publication was increased to 7 issues annually as of 2018, the Drug and Alcohol Review presents original research, policy development and information in the drug and alcohol research field. The journal is an international forum for the views, expertise and experience of all those involved in the study of treatment of alcohol, tobacco and drug problems. The journal represents an important source of information to clinicians, drug and alcohol agency staff, researchers, policy makers, and alcohol service administrators.

Please consider this when writing your abstract, structure it accordingly (including any relevant data) and proofread abstracts carefully to avoid errors before submission.

Abstract Mentor Program

The goal of the APSAD Darwin 2022 Abstract Mentor Program is to provide an opportunity for First Peoples (Aboriginal, Torres Strait Islander and Māori), Community Groups, people with lived experience, and Early Career Researchers to have their draft abstracts mentored by more experienced authors before submitting their abstract to the conference.

Abstracts submitted by authors that have volunteered to be a mentor in the program will not automatically be accepted. The same applies for abstracts submitted by authors that were mentored by the program.

For more information please check the relevant Abstract Mentor Program page.